Taro Pharmaceutical Industries Ltd. to Reschedule Shareholders Meeting on Proposed Merger with Sun Pharmaceutical Industries Ltd Following the Availability of Financial Results

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. ("Taro," the “Company,” Pink Sheets: TAROF) today announced that it will reschedule its shareholders meeting, previously scheduled for September 25, 2007, on the proposed merger with Sun Pharmaceutical Industries Ltd. ("Sun," Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715), to a time following the availability of financial results for the year ended December 31, 2006 and for the first and second quarters of 2007.
MORE ON THIS TOPIC